About Bio-Pharmaceuticals Logistics
Cold chain logistics accounted for the lowest section of the Biopharmaceuticals Logistics market, valued at USD14.6 billion, while non-cold chain logistics accounted for the biggest segment, valued at USD 69 billion. The increase in pharmaceutical businesses outsourcing logistics services to third-party logistics service providers is the key reason driving the 3.72 percent annual growth of non-cold-chain logistics through 2021. Biopharmaceutical Logistics is the coordination of biopharmaceutical, cautious and clinical supplies, and other things intended to support wellbeing specialists, medical caregivers, and dental care, suppliers. The growing number of biosimilar supporters worldwide, the developing pattern of contemplating coordinations, and the improvement of a medicine distribution network as a result of its business numbers are a few of the factors driving the expansion of the biopharmaceutical coordinations market.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Bio-Pharmaceuticals Logistics market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Bio-Pharmaceutical Logistics (Belgium), Amerisource Bergen Corporation (United States), C.H. Robinson Worldwide, Inc. (United States), Ceva Logistics LLC(Netherlands), Deutsche Post DHL Group (Germany), Fedex Corporation (United States), Kuehne + Nagel International AG (Switzerland), Panalpina Group (Switzerland), United Parcel Service, Inc. (United States) and XPO Logistics, Inc.( United States) are some of the key players that are part of study coverage.
Segmentation Overview
AMA Research has segmented the market of Global Bio-Pharmaceuticals Logistics market by Type (Cold Chain Logistics and Non-Cold Chain Logistics) and Region.
On the basis of geography, the market of Bio-Pharmaceuticals Logistics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Mode Of Transportation, the sub-segment i.e. Air Shipping will boost the Bio-Pharmaceuticals Logistics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Operation, the sub-segment i.e. Domestic will boost the Bio-Pharmaceuticals Logistics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Component, the sub-segment i.e. Storage will boost the Bio-Pharmaceuticals Logistics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Offerings, the sub-segment i.e. Software will boost the Bio-Pharmaceuticals Logistics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Consolidation in the global bio-pharmaceuticals logistics market and Technological advancement to contribute to growth bio-pharmaceuticals logistics
Market Growth Drivers:
The increasing hype around targeted therapies, biologics, and personalized medicines demand better temperature control measures in the biopharmaceutical supply chain
Challenges:
The concern of transportation safety
Restraints:
The cost of operation is quite high and Highly regulated market
Opportunities:
Expansion in the demand for cellular therapies, vaccines, and blood products in the Bio-pharmaceutical industry driving the growth of the Bio-pharmaceutical logistics market across the globe.
Market Leaders and their expansionary development strategies
In July 2023, PHSE, a leading pharmaceutical logistics group, announces that it has completed the acquisition of 80% of Air Plus Srl and Bio Pharma Logistics Srl, Italian companies with a strong specialisation in the temperature-controlled transportation of pharmaceuticals, diagnostic samples and biologicals, especially in the international arena (import and export from Italy). One of the founders, Stefano Cazzulani, will retain 20% of both companies and the management direction of them.
In June 2022, NX Group has positioned the pharmaceutical industry as a priority industry and is moving forward in developing quality control systems and improving its business infrastructure both inside and outside Japan in accordance with the Good Distribution Practices (GDP) established for pharmaceuticals.
Key Target Audience
Bio-Pharmaceuticals Logistics Service Providers, Pharmaceutical Manufacturers, Potential Investors, Government agencies and Research and Academic Institutes
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.